Cargando…
Comparison between immunotherapy efficacy in early non-small cell lung cancer and advanced non-small cell lung cancer: a systematic review
BACKGROUND: Currently, immunotherapy is widely used in the treatment of various stages of non-small cell lung cancer. According to clinical experience and results of previous studies, immunotherapy as neoadjuvant therapy seems to exhibit better efficacy against early resectable non-small cell lung c...
Autores principales: | Wang, Yimin, Li, Chuling, Wang, Zimu, Wang, Zhaofeng, Wu, Ranpu, Wu, Ying, Song, Yong, Liu, Hongbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641944/ https://www.ncbi.nlm.nih.gov/pubmed/36345004 http://dx.doi.org/10.1186/s12916-022-02580-1 |
Ejemplares similares
-
A narrative review of progress in diagnosis and treatment of small cell lung cancer patients with hyponatremia
por: Wu, Ranpu, et al.
Publicado: (2020) -
A narrative review of advances in treatment and survival prognosis of HER2-positive malignant lung cancers
por: Wu, Ranpu, et al.
Publicado: (2021) -
Efficacy and safety of first-line PD-1/PD-L1 inhibitor combinations for extensive-stage small-cell lung cancer: a Bayesian network meta-analysis
por: Li, Huijuan, et al.
Publicado: (2023) -
A Multicenter Retrospective Study on the Prognosis of Stage III Unresectable Mutant Non-Small Cell Lung Cancer With Tyrosine Kinase Inhibitors Therapy
por: Wu, Ranpu, et al.
Publicado: (2021) -
Advances in efficacy prediction and monitoring of neoadjuvant immunotherapy for non-small cell lung cancer
por: Wang, Yunzhen, et al.
Publicado: (2023)